These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22239991)

  • 1. Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there?
    Montironi R; Scarpelli M; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montorsi F
    Eur Urol; 2012 Apr; 61(4):751-6. PubMed ID: 22239991
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predicting prostatic biopsy Gleason sum under grading.
    Stackhouse DA; Sun L; Schroeck FR; Jayachandran J; Caire AA; Acholo CO; Robertson CN; Albala DM; Polascik TJ; Donatucci CF; Maloney KE; Moul JW
    J Urol; 2009 Jul; 182(1):118-22; discussion 123-4. PubMed ID: 19447436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal fine-needle aspiration and truecut needle biopsy of the prostate: a blinded comparison of accuracy.
    Klotz LH; Shaw PA; Srigley JR
    Can J Surg; 1989 Jul; 32(4):287-9. PubMed ID: 2660974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
    Mayes JM; Mouraviev V; Sun L; Tsivian M; Madden JF; Polascik TJ
    Urol Oncol; 2011; 29(2):166-70. PubMed ID: 19451000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate biopsy 1999: strategies and significance of pathological findings.
    Iczkowski KA; Bostwick DG
    Semin Urol Oncol; 1999 Nov; 17(4):177-86. PubMed ID: 10632119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S; Trock BJ; Netto GJ; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR; Bostwick DG; Myers RP; Oesterling JE
    J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance.
    Ochiai A; Trpkov K; Yilmaz A; Donnelly B; Babaian RJ
    J Urol; 2007 Mar; 177(3):907-10. PubMed ID: 17296373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathologist's role: to diagnose prostatic cancer and determine prognosis].
    Egevad L
    Lakartidningen; 2012 Feb 22-28; 109(8):403-6. PubMed ID: 22509665
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical problems of systematic prostate needle biopsy in the detection of prostate cancer].
    Suzuki H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):16-20. PubMed ID: 12557699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.
    Chun FK; Epstein JI; Ficarra V; Freedland SJ; Montironi R; Montorsi F; Shariat SF; Schröder FH; Scattoni V
    Eur Urol; 2010 Dec; 58(6):851-64. PubMed ID: 20884114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.
    Montironi R; Mazzuccheli R; Scarpelli M; Lopez-Beltran A; Fellegara G; Algaba F
    BJU Int; 2005 Jun; 95(8):1146-52. PubMed ID: 15877724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gleason pattern 5 adenocarcinoma in prostate needle biopsy.
    Humphrey PA
    J Urol; 2012 Oct; 188(4):1341-2. PubMed ID: 22906668
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer.
    Thickman D; Speers WC; Philpott PJ; Shapiro H
    J Urol; 1996 Jul; 156(1):110-3. PubMed ID: 8648769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of tumour measurements in prostate needle core biopsy specimens.
    López JI
    Histopathology; 2009 Feb; 54(3):374. PubMed ID: 19236515
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 20. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
    Kibel AS
    J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.